Market Tracker

07/24 5:16pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.45
Delayed Data
As of Jul 24
 -0.02 / -0.81%
Today’s Change
1.65
Today|||52-Week Range
5.70
+40.80%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close2.47
Today’s open2.44
Day’s range2.43 - 2.50
Volume51,852
Average volume (3 months)159,838
Market cap$37.6M
Dividend yield--
Data as of 3:59pm ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-486.31%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...+0.02+2.75%
EBIOEleven Biotherapeuti...+0.06+3.97%
NVUSNovus Therapeutics I...-0.09-1.64%
MRNSMarinus Pharmaceutic...+0.10+5.85%
Data as of 7:59pm ET, 07/24/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$2.40
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts